Accelerated fracture healing with teriparatide

Borges, João Lindolfo C

doi:10.1590/2359-3997000000016

On December 2, 2013, it was called our attention that the case report (¹) contained few paragraphs that bear a likeness to a further review (²). This occurred inadvertently when we entrusted the literature and a draft of this review (²) to others co-authors. Although we were not aware of theses similarities between the case report and this review. We nevertheless take full responsibility for this error.

The primary objective of our case report (¹) is to describe a accelerated fracture healing with teriparatide. It thus is completely different in focus, content, and scope from Goldhahn and cols. review (²). We deeply regret this error and apologize for it to all ABE&M readership.

REFERENCES

¹Borges JLC, Freitas A, Bilezikian JP. Accelerated fracture healing with teriparatide. Arq Bras Endocrinol Metab. 2013;57(2):153-6.
²Goldhahn J, Feron JM, Kanis J, Papalous S, Reginster JY, Rizzoli R, et al. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int. 2012;90(5):343-53.

Publication Dates

Publication in this collection
Feb 2015

History

Received
15 Jan 2015
Accepted
15 Jan 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

[1] ¹Borges JLC, Freitas A, Bilezikian JP. Accelerated fracture healing with teriparatide. Arq Bras Endocrinol Metab. 2013;57(2):153-6.

[2] ²Goldhahn J, Feron JM, Kanis J, Papalous S, Reginster JY, Rizzoli R, et al. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int. 2012;90(5):343-53.